AIRAmed GmbH

Make a difference! Thats what drives us. Our goal? To improve medical care across the spectrum of neurodegenerative diseases. That is why we put our heart and soul and our expertise from more than 20 years of university clinical experience into the development of innovative software solutions based on neural networks. They add a decisive factor - objective measurability - to existing radiological reporting. Approximately 64.8 million people worldwide are currently affected by dementia. Thats why dementia is the second most feared disease in society after cancer. This makes it all the more important to develop quantitative software solutions that enable early detection of dementia and other neurodegenerative diseases, including Alzheimers, Parkinsons and multiple sclerosis. For better medicine in the future, for the benefit of the patient. AIRAscore software solutions enable standardized and objective findings based on exact measurement values. Thus, deviations can be detected at ...